Check-Cap Ltd.
$1.9
▲
1.11%
2026-04-21 08:03:01
check-cap.com
NCM: MBAI
Explore Check-Cap Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$13.56 M
Current Price
$1.9
52W High / Low
$3.92 / $0.59
Stock P/E
—
Book Value
$0.64
Dividend Yield
—
ROCE
659.83%
ROE
-1.3%
Face Value
—
EPS
$-2.33
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
—
Beta
0.79
Debt / Equity
3.69
Current Ratio
0.71
Quick Ratio
0.15
Forward P/E
—
Price / Sales
—
Enterprise Value
$8.55 M
EV / EBITDA
-2.28
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Return on equity is on the weaker side.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Medpace Holdings, Inc. | $513.23 | 33.75 | $14.67 B | — | 84.68% | 70.23% | $628.92 / $250.05 | $16.18 |
| 2. | Illumina, Inc. | $131.09 | 24.09 | $19.95 B | — | 16.15% | 33.36% | $155.53 / $69.83 | $17.8 |
| 3. | IDEXX Laboratories, Inc. | $580.27 | 44.49 | $46.26 B | — | 61.76% | 66.2% | $769.98 / $402.85 | $20.14 |
| 4. | GRAIL, Inc. | $51.2 | — | $2.1 B | — | -18.79% | -16.07% | $118.84 / $25.56 | $63.92 |
| 5. | bioAffinity Technologies, Inc. | $2.69 | — | $12.87 M | — | -131.93% | -3.02% | $17.44 / $0.69 | $1.62 |
| 6. | Revvity, Inc. | $93.89 | 28.42 | $10.54 B | 0.3% | 3.29% | 3.22% | $118.3 / $81.36 | $64.57 |
| 7. | Qiagen N.V. | NOT FOUND | — | — | 0.64% | 9.02% | 11.57% | $57.81 / $38.8 | $18.33 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -9.46 M | -17.77 M | -20 M | -17.3 M |
| Net Profit | -25.15 M | -17.57 M | -19.11 M | -17.2 M |
| EPS in Rs | -3.45 | -2.41 | -2.62 | -2.36 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 0.38 M | 25.02 M | 45.44 M | 55.66 M |
| Total Liabilities | 1.83 M | 1.33 M | 4.13 M | 4.97 M |
| Equity | -1.45 M | 23.69 M | 41.31 M | 50.69 M |
| Current Assets | 0.27 M | 24.86 M | 42.63 M | 52.75 M |
| Current Liabilities | 1.81 M | 1.33 M | 3.41 M | 4.04 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -8 M | -16.95 M | -18.71 M | -16.26 M |
| Investing CF | -0.84 M | 21.36 M | -12.51 M | -16.01 M |
| Financing CF | 0 M | 0 M | 8.85 M | 51.02 M |
| Free CF | -8 M | -17.04 M | -19.19 M | -17.27 M |
| Capex | — | -0.08 M | -0.49 M | -1.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -43.15% | 8.06% | -11.08% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2022-11-25 | 1:0.05 |